GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 2,670.00
0.00 (0.00%)
Last updated: Jul 16, 2026, 9:00 AM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 48.42 billion as of July 20, 2026. Its market cap has decreased by -76.57% in one year.
Market Cap
48.42B
Enterprise Value
76.85B
Revenue
17.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,670.00
ChartMarket Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 48.42B, an increase of 1,324.11%. That is a compound annual growth rate of 8.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 48.42B | -70.99% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 106.88B |
| Vaxcell-Bio Therapeutics | 96.40B |
| MedPacto | 92.37B |
| Amicogen | 82.36B |
| iNtRON Biotechnology | 79.35B |
| ENCell | 72.13B |
| CG Invites | 67.97B |
| Prestige BioPharma | 63.58B |